Multiple Sclerosis Community
9.23k Members
5538989 tn?1514398453

Rituxan: What is your experience, good or bad?

I haven't had to post in a long time. I have 2 new lesions after much success with Tecfidera and my Neuro would like me to go to Rituxan. He is stating it is the most effective for me as I cannot do Tysabri and refuse Gilyena.

The increased risk of both breast and cervical cancer scare the hell out of me. I feel like I am mitigating MS at the expense of something far greater than I consider MS. Is my thought process incorrect?

I love that I do not have side effects from Tecfidera and until last year it was actually healing and decreasing old lesions. I'm so conflicted.

Any thoughts, advice and experiences are welcome. I'm glad I know I can always come back here for solid feedback.

Happy New Year,
1 Responses
987762 tn?1331027953
Hi Lizzie, unfortunately the forum is really quiet at the moment so that solid feed back may be short on coming sorry....i had a look through posting history and there are quite a few previous discussions on Rituxan that you might find helpful. Here's the link but if you can't get it to come up just type in 'Rituxan' in the pale blue box, top right of your screen.


Really sorry but that's all i have for you at this time.....JJ
Have an Answer?
Top Neurology Answerers
987762 tn?1331027953
5265383 tn?1483808356
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease